TCWM
PHIO icon

Total Clarity Wealth Management’s Phio Pharmaceuticals PHIO Stock Holding History

Total Clarity Wealth Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14
Closed -$3K – 1042
2021
Q3 		$3K Buy
+14
New +$2.92K ﹤0.01% 897
2021
Q2 		– Sell
-14
Closed -$4K – 590
2021
Q1 		$4K Buy
+14
New +$4.65K ﹤0.01% 734

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Total Clarity Wealth Management's PHIO Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Phio Pharmaceuticals (PHIO) in Q4 2021, closing a stake of 14 shares — an estimated $3K sold.

Total Clarity Wealth Management first reported a position in PHIO in Q1 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 16 funds tracked by Wall St. Rank hold PHIO as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Phio Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 14 Phio Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Total Clarity Wealth Management first reported a position in Phio Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Total Clarity Wealth Management's Phio Pharmaceuticals position peaked at $4K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.